A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)

Trial Profile

A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients With Moderately Severe Alcoholic Hepatitis (AH)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Obeticholic acid (Primary)
  • Indications Alcoholic hepatitis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TREAT
  • Most Recent Events

    • 04 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 18 Jun 2014 Last checked against Mayo Clinic record.
    • 10 Apr 2014 Planned initiation date changed from 1 Mar 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top